These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18683868)

  • 1. Antithymocyte globulin therapy for steroid-resistant acute graft versus host disease.
    Ballesteros M; Ferrá C; Serrano D; Batlle M; Ribera JM; Díez-Martín JL
    Am J Hematol; 2008 Oct; 83(10):824-5. PubMed ID: 18683868
    [No Abstract]   [Full Text] [Related]  

  • 2. A phase 2/3 multicenter randomized clinical trial of ABX-CBL versus ATG as secondary therapy for steroid-resistant acute graft-versus-host disease.
    Macmillan ML; Couriel D; Weisdorf DJ; Schwab G; Havrilla N; Fleming TR; Huang S; Roskos L; Slavin S; Shadduck RK; Dipersio J; Territo M; Pavletic S; Linker C; Heslop HE; Deeg HJ; Blazar BR
    Blood; 2007 Mar; 109(6):2657-62. PubMed ID: 17110457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of antithymocyte globulin for treatment of steroid-refractory acute graft-versus-host disease: an international practice survey.
    Hsu B; May R; Carrum G; Krance R; Przepiorka D
    Bone Marrow Transplant; 2001 Nov; 28(10):945-50. PubMed ID: 11753549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reader comments on antithymocyte globulin use for aplastic anemia.
    Eisenberg S
    Clin J Oncol Nurs; 2004 Dec; 8(6):583; author reply 583. PubMed ID: 15637953
    [No Abstract]   [Full Text] [Related]  

  • 5. Favourable response to antithymocyte globulin therapy in resistant acute graft-versus-host disease.
    Tagliabue A; Corti P; Viganò E; Bonanomi S; Uderzo C
    Bone Marrow Transplant; 2005 Sep; 36(5):459. PubMed ID: 15980883
    [No Abstract]   [Full Text] [Related]  

  • 6. Antithymocyte globulin as the primary treatment for renal allograft rejection.
    Nelson PW; Cosimi AB; Delmonico FL; Rubin RH; Tolkoff-Rubin NE; Fang L; Russell PS
    Transplantation; 1983 Nov; 36(5):587-9. PubMed ID: 6356523
    [No Abstract]   [Full Text] [Related]  

  • 7. Update on the management of acute graft-versus-host disease.
    Bolaños-Meade J
    Curr Opin Oncol; 2006 Mar; 18(2):120-5. PubMed ID: 16462179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.
    Kim HJ; Min WS; Cho BS; Eom KS; Kim YJ; Min CK; Lee S; Cho SG; Jin JY; Lee JW; Kim CC
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):704-17. PubMed ID: 19450755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical utility of rituximab in chronic graft-versus-host disease.
    Bates JS; Engemann AM; Hammond JM
    Ann Pharmacother; 2009 Feb; 43(2):316-21. PubMed ID: 19193571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic graft-versus-host disease (GVHD) [proceedings].
    Kolb HJ; Wundisch GF; Bender C; Rodt H; Thiel E; Grosse-Wilde H; Thierfelder S
    Pathol Biol (Paris); 1978 Jan; 26(1):52. PubMed ID: 358092
    [No Abstract]   [Full Text] [Related]  

  • 11. HLA-mismatched unrelated donors as an alternative graft source for allogeneic stem cell transplantation after antithymocyte globulin-containing conditioning regimen.
    Kröger N; Zabelina T; Binder T; Ayuk F; Bacher U; Amtsfeld G; Lellek H; Schrum J; Erttmann R; Eiermann T; Zander A
    Biol Blood Marrow Transplant; 2009 Apr; 15(4):454-62. PubMed ID: 19285633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute graft-versus-host disease after liver transplant: novel use of etanercept and the role of tumor necrosis factor alpha inhibitors.
    Thin L; Macquillan G; Adams L; Garas G; Seow C; Cannell P; Augustson B; Mitchell A; Delriveire L; Jeffrey G
    Liver Transpl; 2009 Apr; 15(4):421-6. PubMed ID: 19326415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127- T regulatory cells.
    Trzonkowski P; Bieniaszewska M; Juścińska J; Dobyszuk A; Krzystyniak A; Marek N; Myśliwska J; Hellmann A
    Clin Immunol; 2009 Oct; 133(1):22-6. PubMed ID: 19559653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second stem cell transplantation in patients with Fanconi anemia using antithymocyte globulin alone for conditioning.
    Ayas M; Al-Jefri A; Al-Seraihi A; Al-Mahr M; Al-Ahmari A; El-Solh H
    Biol Blood Marrow Transplant; 2008 Apr; 14(4):445-8. PubMed ID: 18342787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does adding ATG to the GVHD prophylaxis regimen help reduce its incidence?
    Ayas M; Al-Mahr M; Al-Jefri A; Rifai S; Solh H
    Bone Marrow Transplant; 2003 Feb; 31(4):311; author reply 313. PubMed ID: 12621470
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunosuppressive problems in organ transplantation].
    Iwainsky H
    Z Erkr Atmungsorgane Folia Bronchol; 1970; 131(3):285-9. PubMed ID: 4395128
    [No Abstract]   [Full Text] [Related]  

  • 17. [Graft-versus-host disease].
    Vázquez Sell L
    Rev Clin Esp; 1986 Sep; 179(4):165-6. PubMed ID: 3764003
    [No Abstract]   [Full Text] [Related]  

  • 18. [Anti-thymocyte globulin for immunosuppression].
    Collste LG; Franksson C; Groth CG; Jacobson S; Magnusson G; Schantz B; Svehag SE; Werner B
    Nord Med; 1971; 86(46):1358. PubMed ID: 4944024
    [No Abstract]   [Full Text] [Related]  

  • 19. Bacteremias and invasive fungal diseases in children receiving etanercept for steroid-resistant acute GVHD.
    Faraci M; Lanino E; Morreale G; Giardino S; Fossati M; Moroni C; Caviglia I; Castagnola E
    Bone Marrow Transplant; 2011 Jan; 46(1):159-60. PubMed ID: 20383214
    [No Abstract]   [Full Text] [Related]  

  • 20. Low-dose antithymocyte globulin for treatment of steroid-pulse-resistant acute graft-versus-host disease.
    Ohashi K; Tanaka Y; Mori S; Okuyama Y; Hiruma K; Akiyama H; Sakamaki H
    Int J Hematol; 2003 Jan; 77(1):99-102. PubMed ID: 12568309
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.